Cases & Deals

Bay City Capital fund invests in Via Pharmaceuticals

Clients Bay City Capital Fund IV

Jones Day represented Bay City Capital Fund IV in connection with its purchase of $10 million of Notes and Warrants and concurrent secured bridge loan to Via Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.